Next Article in Journal
Targeting Heat Shock Protein 27 in Cancer: A Druggable Target for Cancer Treatment?
Next Article in Special Issue
Baseline Genomic Features in BRAFV600-Mutated Metastatic Melanoma Patients Treated with BRAF Inhibitor + MEK Inhibitor in Routine Care
Previous Article in Journal
Development, Implementation and Assessment of Molecular Diagnostics by Next Generation Sequencing in Personalized Treatment of Cancer: Experience of a Public Reference Healthcare Hospital
Previous Article in Special Issue
Adaptive Responses as Mechanisms of Resistance to BRAF Inhibitors in Melanoma
 
 
Review

Article Versions Notes

Cancers 2019, 11(8), 1197; https://doi.org/10.3390/cancers11081197
Action Date Notes Link
article xml file uploaded 16 August 2019 15:21 CEST Original file -
article pdf uploaded. 16 August 2019 15:21 CEST Version of Record https://www.mdpi.com/2072-6694/11/8/1197/pdf-vor
article xml file uploaded 21 August 2019 08:21 CEST Update -
article xml uploaded. 21 August 2019 08:21 CEST Update -
article pdf uploaded. 21 August 2019 08:21 CEST Updated version of record https://www.mdpi.com/2072-6694/11/8/1197/pdf-vor
article xml file uploaded 21 August 2019 09:30 CEST Update -
article xml uploaded. 21 August 2019 09:30 CEST Update https://www.mdpi.com/2072-6694/11/8/1197/xml
article pdf uploaded. 21 August 2019 09:30 CEST Updated version of record https://www.mdpi.com/2072-6694/11/8/1197/pdf
article html file updated 21 August 2019 09:31 CEST Original file -
article html file updated 28 August 2019 05:13 CEST Update -
article html file updated 13 February 2020 10:23 CET Update -
article html file updated 20 July 2022 05:06 CEST Update https://www.mdpi.com/2072-6694/11/8/1197/html
Back to TopTop